Puma Biotech (PBYI) Reports Q3 EPS of $0.17

Puma Biotech (NASDAQ: PBYI) reported Q3 EPS of $0.17, versus ($1.36) reported last year. Revenue for the quarter came in at $62.6 million versus the consensus estimate of $57.94 million.

For earnings history and earnings-related data on Puma Biotech (PBYI) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• UBS Reiterates Buy Rating on General Motors (GM) as Defense Opportunity in Focus
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance